More recently, a study demonstrated that PRDM2/RIZ1 could lead to G2/M arrest of meningioma cells by acting on the expression of the checkpoint protein UbcH10, an important member of the ubiquitin-conjugating enzymes family, through c-Myc degradation [83]. Here, PRDM2 is linked to meningioma.